Literature DB >> 3985606

Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis.

S K Wray, B E Gilbert, M W Noall, V Knight.   

Abstract

Ribavirin, a guanosine analogue, is a broad spectrum antiviral agent which is effective in the treatment of influenza. In this study, the effect of ribavirin on influenza virus ribonucleoprotein (RNP) synthesis and nucleotide pool sizes was simultaneously measured. Ribavirin (100 microM) reduced viral RNP synthesis 94% as measured by UTP incorporation. Intracellular GTP pools, measured by high performance liquid chromatography, were reduced approximately 45% in ribavirin treated cells, while other nucleotides remained near control values. Attempts to reverse ribavirin's inhibitory effects on viral RNP synthesis by addition of exogenous guanosine (50 microM) resulted in only a partial restoration of viral RNP synthesis, despite full restoration of the GTP pool. Dose-response experiments indicated that the GTP pool was significantly reduced (65% of control) at 25 microM ribavirin, and increasing concentrations of the drug caused only a small further reduction in the GTP pool (5-10% at 100 microM). In contrast, RNP synthesis was inhibited by 50% at 25 microM ribavirin and was further decreased to 5% of control at 100 microM ribavirin. Thus, ribavirin's antiviral activity may result from a reduction of the GTP pool size combined with direct effects on viral replicative enzymes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3985606     DOI: 10.1016/0166-3542(85)90012-9

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  38 in total

1.  Mechanism of action of ribavirin in the treatment of chronic hepatitis C.

Authors:  Helen S Te; Glenn Randall; Donald M Jensen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-03

2.  Mechanism of action of T-705 against influenza virus.

Authors:  Yousuke Furuta; Kazumi Takahashi; Masako Kuno-Maekawa; Hidehiro Sangawa; Sayuri Uehara; Kyo Kozaki; Nobuhiko Nomura; Hiroyuki Egawa; Kimiyasu Shiraki
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 3.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

4.  Purine synthesis promotes maintenance of brain tumor initiating cells in glioma.

Authors:  Xiuxing Wang; Kailin Yang; Qi Xie; Qiulian Wu; Stephen C Mack; Yu Shi; Leo J Y Kim; Briana C Prager; William A Flavahan; Xiaojing Liu; Meromit Singer; Christopher G Hubert; Tyler E Miller; Wenchao Zhou; Zhi Huang; Xiaoguang Fang; Aviv Regev; Mario L Suvà; Tae Hyun Hwang; Jason W Locasale; Shideng Bao; Jeremy N Rich
Journal:  Nat Neurosci       Date:  2017-03-27       Impact factor: 24.884

Review 5.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase.

Authors:  Yanjie Sun; Dong-Hoon Chung; Yong-Kyu Chu; Colleen B Jonsson; William B Parker
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

Review 7.  Biochemistry and clinical applications of ribavirin.

Authors:  B E Gilbert; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

8.  Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.

Authors:  Evelien Vanderlinden; Bram Vrancken; Jeroen Van Houdt; Vivek K Rajwanshi; Sarah Gillemot; Graciela Andrei; Philippe Lemey; Lieve Naesens
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

9.  Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction.

Authors:  R Fernandez-Larsson; K O'Connell; E Koumans; J L Patterson
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

10.  Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin.

Authors:  Nirav R Shah; Amanda Sunderland; Valery Z Grdzelishvili
Journal:  PLoS One       Date:  2010-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.